{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:20:23Z","timestamp":1780719623661,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG043540"],"award-info":[{"award-number":["AG043540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA028555"],"award-info":[{"award-number":["DA028555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS036126"],"award-info":[{"award-number":["NS036126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS034239"],"award-info":[{"award-number":["NS034239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH064570"],"award-info":[{"award-number":["MH064570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS043985"],"award-info":[{"award-number":["NS043985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH062261"],"award-info":[{"award-number":["MH062261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH086372"],"award-info":[{"award-number":["MH086372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA037611"],"award-info":[{"award-number":["DA037611"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH104145"],"award-info":[{"award-number":["MH104145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA037611"],"award-info":[{"award-number":["DA037611"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH104145"],"award-info":[{"award-number":["MH104145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS094146"],"award-info":[{"award-number":["NS094146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["421-20-09A"],"award-info":[{"award-number":["421-20-09A"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s13365-018-0629-1","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:03:33Z","timestamp":1522242213000},"page":"398-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice"],"prefix":"10.1007","volume":"24","author":[{"given":"Katherine E.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya N.","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Namminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Potash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa Y.","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Volsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"629_CR1","doi-asserted-by":"publisher","first-page":"e1376","DOI":"10.1371\/journal.pone.0001376","volume":"3","author":"EJ Benner","year":"2008","unstructured":"Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE (2008) Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One 3:e1376","journal-title":"PLoS One"},{"key":"629_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/026988110001400304","volume":"14","author":"JR Berger","year":"2000","unstructured":"Berger JR, Arendt G (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14:214\u2013221","journal-title":"J Psychopharmacol"},{"key":"629_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/01.wnl.0000489939.73359.c3","volume":"87","author":"JT Boyd","year":"2016","unstructured":"Boyd JT, Wangensteen KJ, Krawitt EL, Hamill RW, Kao CH, Tsai HH (2016) Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 87:342","journal-title":"Neurology"},{"key":"629_CR4","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192","journal-title":"J Clin Invest"},{"key":"629_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O'Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383","journal-title":"Exp Neurol"},{"key":"629_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2165\/00023210-200216100-00002","volume":"16","author":"F Cardoso","year":"2002","unstructured":"Cardoso F (2002) HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 16:663\u2013668","journal-title":"CNS Drugs"},{"key":"629_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.bjid.2012.11.007","volume":"17","author":"SW Cardoso","year":"2013","unstructured":"Cardoso SW, Torres TS, Santini-Oliveira M, Marins LM, Veloso VG, Grinsztejn B (2013) Aging with HIV: a practical review. Braz J Infect Dis 17:464\u2013479","journal-title":"Braz J Infect Dis"},{"key":"629_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41467-017-01795-8","volume":"8","author":"Q Chai","year":"2017","unstructured":"Chai Q, Jovasevic V, Malikov V, Sabo Y, Morham S, Walsh D, Naghavi MH (2017) HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun 8:1522","journal-title":"Nat Commun"},{"key":"629_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","volume":"13","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13:976\u2013986","journal-title":"Lancet Infect Dis"},{"key":"629_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","volume":"42","author":"LE Davis","year":"1992","unstructured":"Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736\u20131739","journal-title":"Neurology"},{"key":"629_CR11","doi-asserted-by":"publisher","first-page":"121ps123","DOI":"10.1126\/scitranslmed.3003492","volume":"4","author":"M Deleidi","year":"2012","unstructured":"Deleidi M, Isacson O (2012) Viral and inflammatory triggers of neurodegenerative diseases. Sci Transl Med 4:121ps123","journal-title":"Sci Transl Med"},{"key":"629_CR12","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1038\/s41598-017-07570-5","volume":"7","author":"AM Dickens","year":"2017","unstructured":"Dickens AM, Yoo SW, Chin AC, Xu J, Johnson TP, Trout AL, Hauser KF, Haughey NJ (2017) Chronic low-level expression of HIV-1 tat promotes a neurodegenerative phenotype with aging. Sci Rep 7:7748","journal-title":"Sci Rep"},{"key":"629_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11065-009-9094-1","volume":"19","author":"RJ Ellis","year":"2009","unstructured":"Ellis RJ, Calero P, Stockin MD (2009) HIV infection and the central nervous system: a primer. Neuropsychol Rev 19:144\u2013151","journal-title":"Neuropsychol Rev"},{"key":"629_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","volume":"26","author":"EA Eugenin","year":"2006","unstructured":"Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006) CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098\u20131106","journal-title":"J Neurosci"},{"key":"629_CR15","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1093\/nar\/gkr1224","volume":"40","author":"G Fiume","year":"2012","unstructured":"Fiume G, Vecchio E, De Laurentiis A, Trimboli F, Palmieri C, Pisano A, Falcone C, Pontoriero M, Rossi A, Scialdone A, Fasanella Masci F, Scala G, Quinto I (2012) Human immunodeficiency virus-1 tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65. Nucleic Acids Res 40:3548\u20133562","journal-title":"Nucleic Acids Res"},{"key":"629_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nbd.2017.04.015","volume":"105","author":"PJ Gaskill","year":"2017","unstructured":"Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H (2017) HIV, tat and dopamine transmission. Neurobiol Dis 105:51\u201373","journal-title":"Neurobiol Dis"},{"key":"629_CR17","doi-asserted-by":"publisher","first-page":"L500","DOI":"10.1152\/ajplung.00431.2016","volume":"312","author":"P Geraghty","year":"2017","unstructured":"Geraghty P, Hadas E, Kim BH, Dabo AJ, Volsky DJ, Foronjy R (2017) HIV infection model of chronic obstructive pulmonary disease in mice. Am J Physiol Lung Cell Mol Physiol 312:L500\u2013L509","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"629_CR18","doi-asserted-by":"publisher","first-page":"e84081","DOI":"10.1371\/journal.pone.0084081","volume":"9","author":"A Groger","year":"2014","unstructured":"Groger A, Kolb R, Schafer R, Klose U (2014) Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PLoS One 9:e84081","journal-title":"PLoS One"},{"key":"629_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/QAD.0b013e3281574549","volume":"21","author":"E Hadas","year":"2007","unstructured":"Hadas E, Borjabad A, Chao W, Saini M, Ichiyama K, Potash MJ, Volsky DJ (2007) Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1. AIDS 21:905\u2013909","journal-title":"AIDS"},{"key":"629_CR20","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","volume":"589","author":"D Haddad","year":"2015","unstructured":"Haddad D, Nakamura K (2015) Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease. FEBS Lett 589:3702\u20133713","journal-title":"FEBS Lett"},{"key":"629_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/NEN.0000000000000026","volume":"73","author":"H He","year":"2014","unstructured":"He H, Sharer LR, Chao W, Gu CJ, Borjabad A, Hadas E, Kelschenbach J, Ichiyama K, Do M, Potash MJ, Volsky DJ (2014) Enhanced human immunodeficiency virus type 1 expression and neuropathogenesis in knockout mice lacking type I interferon responses. J Neuropathol Exp Neurol 73:59\u201371","journal-title":"J Neuropathol Exp Neurol"},{"key":"629_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/aid.2011.0297","volume":"28","author":"JC Hernandez","year":"2012","unstructured":"Hernandez JC, Stevenson M, Latz E, Urcuqui-Inchima S (2012) HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro. AIDS Res Hum Retrovir 28:1313\u20131328","journal-title":"AIDS Res Hum Retrovir"},{"issue":"Suppl 1","key":"629_CR23","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"key":"629_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.10.008","volume":"45","author":"S Hong","year":"2015","unstructured":"Hong S, Banks WA (2015) Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun 45:1\u201312","journal-title":"Brain Behav Immun"},{"key":"629_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1389450116666150531162212","volume":"17","author":"XT Hu","year":"2016","unstructured":"Hu XT (2016) HIV-1 tat-mediated calcium dysregulation and neuronal dysfunction in vulnerable brain regions. Curr Drug Targets 17:4\u201314","journal-title":"Curr Drug Targets"},{"key":"629_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2:141\u2013151","journal-title":"Nat Protoc"},{"key":"629_CR27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","volume":"1792","author":"H Jang","year":"2009","unstructured":"Jang H, Boltz DA, Webster RG, Smeyne RJ (2009) Viral parkinsonism. Biochim Biophys Acta 1792:714\u2013721","journal-title":"Biochim Biophys Acta"},{"key":"629_CR28","first-page":"302","volume":"4","author":"J Jin","year":"2012","unstructured":"Jin J, Lam L, Sadic E, Fernandez F, Tan J, Giunta B (2012) HIV-1 tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: a potential new treatment target for HAND. Am J Transl Res 4:302\u2013315","journal-title":"Am J Transl Res"},{"key":"629_CR29","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1523\/JNEUROSCI.5522-06.2007","volume":"27","author":"GJ Jones","year":"2007","unstructured":"Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C (2007) HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 27:3703\u20133711","journal-title":"J Neurosci"},{"key":"629_CR30","doi-asserted-by":"publisher","first-page":"e0151702","DOI":"10.1371\/journal.pone.0151702","volume":"11","author":"LD Jones","year":"2016","unstructured":"Jones LD, Jackson JW, Maggirwar SB (2016) Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction. PLoS One 11:e0151702","journal-title":"PLoS One"},{"key":"629_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00005072-199806000-00004","volume":"57","author":"M Jones","year":"1998","unstructured":"Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A (1998) Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 57:563\u2013570","journal-title":"J Neuropathol Exp Neurol"},{"key":"629_CR32","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"629_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2174\/187152731307141015122638","volume":"13","author":"S Karim","year":"2014","unstructured":"Karim S, Mirza Z, Kamal MA, Abuzenadah AM, Azhar EI, Al-Qahtani MH, Damanhouri GA, Ahmad F, Gan SH, Sohrab SS (2014) The role of viruses in neurodegenerative and neurobehavioral diseases. CNS Neurol Disord Drug Targets 13:1213\u20131223","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"629_CR34","first-page":"131","volume":"15","author":"N Khanlou","year":"2009","unstructured":"Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP (2009) Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neuro-Oncol 15:131\u2013138","journal-title":"J Neuro-Oncol"},{"key":"629_CR35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1242\/bio.013201","volume":"4","author":"JS Knibbe-Hollinger","year":"2015","unstructured":"Knibbe-Hollinger JS, Fields NR, Chaudoin TR, Epstein AA, Makarov E, Akhter SP, Gorantla S, Bonasera SJ, Gendelman HE, Poluektova LY (2015) Influence of age, irradiation and humanization on NSG mouse phenotypes. Biol Open 4:1243\u20131252","journal-title":"Biol Open"},{"key":"629_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","volume":"265","author":"LM Kosloski","year":"2013","unstructured":"Kosloski LM, Kosmacek EA, Olson KE, Mosley RL, Gendelman HE (2013) GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice. J Neuroimmunol 265:1\u201310","journal-title":"J Neuroimmunol"},{"key":"629_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312\u2013318","journal-title":"Trends Neurosci"},{"key":"629_CR38","first-page":"257","volume":"15","author":"AM Kumar","year":"2009","unstructured":"Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neuro-Oncol 15:257\u2013274","journal-title":"J Neuro-Oncol"},{"key":"629_CR39","first-page":"26","volume":"17","author":"AM Kumar","year":"2011","unstructured":"Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011) Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neuro-Oncol 17:26\u201340","journal-title":"J Neuro-Oncol"},{"key":"629_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/exnr.1998.6993","volume":"156","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, Czlonkowski A, Czlonkowska A (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50\u201361","journal-title":"Exp Neurol"},{"key":"629_CR41","first-page":"208","volume":"21","author":"DS Kwon","year":"2010","unstructured":"Kwon DS, Kaufmann DE (2010) Protective and detrimental roles of IL-10 in HIV pathogenesis. Eur Cytokine Netw 21:208\u2013214","journal-title":"Eur Cytokine Netw"},{"key":"629_CR42","doi-asserted-by":"crossref","unstructured":"Li W, Gorantla S, Gendelman HE, Poluektova LY (2017) Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains. Dis Model Mech 10:1489-1502","DOI":"10.1242\/dmm.031773"},{"key":"629_CR43","doi-asserted-by":"publisher","first-page":"e23915","DOI":"10.1371\/journal.pone.0023915","volume":"6","author":"SM Lu","year":"2011","unstructured":"Lu SM, Tremblay ME, King IL, Qi J, Reynolds HM, Marker DF, Varrone JJ, Majewska AK, Dewhurst S, Gelbard HA (2011) HIV-1 tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 6:e23915","journal-title":"PLoS One"},{"key":"629_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","volume":"4","author":"JC McArthur","year":"2005","unstructured":"McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543\u2013555","journal-title":"Lancet Neurol"},{"key":"629_CR45","doi-asserted-by":"publisher","unstructured":"Meeker RB, Hudson L (2017) Feline immunodeficiency virus neuropathogenesis: a model for HIV-induced CNS inflammation and neurodegeneration. Vet Sci 4(1). \n                    https:\/\/doi.org\/10.3390\/vetsci4010014","DOI":"10.3390\/vetsci4010014"},{"key":"629_CR46","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.870130413","volume":"13","author":"SM Mirsattari","year":"1998","unstructured":"Mirsattari SM, Power C, Nath A (1998) Parkinsonism with HIV infection. Mov Disord 13:684\u2013689","journal-title":"Mov Disord"},{"key":"629_CR47","unstructured":"Mochizuki H, Yamada M, Mizuno Y (2006) Alpha-synuclein overexpression model. J Neural Transm Suppl (70):281-284"},{"key":"629_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/QAI.0000000000000677","volume":"70","author":"A Moulignier","year":"2015","unstructured":"Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C (2015) Does HIV infection alter Parkinson disease? J Acquir Immune Defic Syndr 70:129\u2013136","journal-title":"J Acquir Immune Defic Syndr"},{"key":"629_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jnc.13409","volume":"136","author":"AB Munoz-Manchado","year":"2016","unstructured":"Munoz-Manchado AB, Villadiego J, Romo-Madero S, Suarez-Luna N, Bermejo-Navas A, Rodriguez-Gomez JA, Garrido-Gil P, Labandeira-Garcia JL, Echevarria M, Lopez-Barneo J, Toledo-Aral JJ (2016) Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice. J Neurochem 136:373\u2013387","journal-title":"J Neurochem"},{"key":"629_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0047-6374(99)00064-0","volume":"111","author":"M Naoi","year":"1999","unstructured":"Naoi M, Maruyama W (1999) Cell death of dopamine neurons in aging and Parkinson\u2019s disease. Mech Ageing Dev 111:175\u2013188","journal-title":"Mech Ageing Dev"},{"key":"629_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.410190602","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517\u2013524","journal-title":"Ann Neurol"},{"key":"629_CR52","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/WNL.0000000000003848","volume":"88","author":"J Pakpoor","year":"2017","unstructured":"Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M (2017) Viral hepatitis and Parkinson disease: a national record-linkage study. Neurology 88:1630\u20131633","journal-title":"Neurology"},{"key":"629_CR53","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1073\/pnas.0500649102","volume":"102","author":"MJ Potash","year":"2005","unstructured":"Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J, Belem P, Sharer L, Brooks AI, Volsky DJ (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A 102:3760\u20133765","journal-title":"Proc Natl Acad Sci U S A"},{"key":"629_CR54","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood.V85.5.1300.bloodjournal8551300","volume":"85","author":"JC Renauld","year":"1995","unstructured":"Renauld JC, Vink A, Louahed J, Van Snick J (1995) Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300\u20131305","journal-title":"Blood"},{"key":"629_CR55","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1590\/S0004-282X2009000500009","volume":"67","author":"AL Rosso","year":"2009","unstructured":"Rosso AL, Mattos JP, Correa RB, Nicaretta DH, Novis SA (2009) Parkinsonism and AIDS: a clinical comparative study before and after HAART. Arq Neuropsiquiatr 67:827\u2013830","journal-title":"Arq Neuropsiquiatr"},{"key":"629_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/clim.2000.4905","volume":"96","author":"WS Sheng","year":"2000","unstructured":"Sheng WS, Hu S, Hegg CC, Thayer SA, Peterson PK (2000) Activation of human microglial cells by HIV-1 gp41 and tat proteins. Clin Immunol 96:243\u2013251","journal-title":"Clin Immunol"},{"key":"629_CR57","first-page":"576","volume":"21","author":"DP Sheppard","year":"2015","unstructured":"Sheppard DP, Iudicello JE, Bondi MW, Doyle KL, Morgan EE, Massman PJ, Gilbert PE, Woods SP (2015) Elevated rates of mild cognitive impairment in HIV disease. J Neuro-Oncol 21:576\u2013584","journal-title":"J Neuro-Oncol"},{"key":"629_CR58","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.neuro.2007.07.005","volume":"28","author":"JM Silvers","year":"2007","unstructured":"Silvers JM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2007) Neurotoxicity of HIV-1 tat protein: involvement of D1 dopamine receptor. Neurotoxicology 28:1184\u20131190","journal-title":"Neurotoxicology"},{"key":"629_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11481-014-9574-9","volume":"10","author":"GM Sindberg","year":"2015","unstructured":"Sindberg GM, Sharma U, Banerjee S, Anand V, Dutta R, Gu CJ, Volsky DJ, Roy S (2015) An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut. J NeuroImmune Pharmacol 10:74\u201387","journal-title":"J NeuroImmune Pharmacol"},{"key":"629_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/016128400248266","volume":"21","author":"PJ Ungvarski","year":"2000","unstructured":"Ungvarski PJ, Trzcianowska H (2000) Neurocognitive disorders seen in HIV disease. Issues Ment Health Nurs 21:51\u201370","journal-title":"Issues Ment Health Nurs"},{"key":"629_CR61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1189\/jlb.0811394","volume":"91","author":"DW Williams","year":"2012","unstructured":"Williams DW, Eugenin EA, Calderon TM, Berman JW (2012) Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91:401\u2013415","journal-title":"J Leukoc Biol"},{"key":"629_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev.neuro.25.112701.142822","volume":"25","author":"KC Williams","year":"2002","unstructured":"Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537\u2013562","journal-title":"Annu Rev Neurosci"},{"key":"629_CR63","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11481-013-9477-1","volume":"8","author":"TW Wilson","year":"2013","unstructured":"Wilson TW, Heinrichs-Graham E, Robertson KR, Sandkovsky U, O'Neill J, Knott NL, Fox HS, Swindells S (2013) Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study. J NeuroImmune Pharmacol 8:965\u2013974","journal-title":"J NeuroImmune Pharmacol"},{"key":"629_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","volume":"53","author":"EJ Wing","year":"2016","unstructured":"Wing EJ (2016) HIV and aging. Int J Infect Dis 53:61\u201368","journal-title":"Int J Infect Dis"},{"key":"629_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/QAI.0b013e318225ba62","volume":"58","author":"ST Wright","year":"2011","unstructured":"Wright ST, Carr A, Woolley I, Giles M, Hoy J, Cooper DA, Law MG (2011) CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts. J Acquir Immune Defic Syndr 58:72\u201379","journal-title":"J Acquir Immune Defic Syndr"},{"key":"629_CR66","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1074\/jbc.275.6.4159","volume":"275","author":"G Zauli","year":"2000","unstructured":"Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, Milani D, Dowd DR, Capitani S, Vitale M (2000) HIV-1 tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 275:4159\u20134165","journal-title":"J Biol Chem"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-018-0629-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-018-0629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-018-0629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T21:55:02Z","timestamp":1589666102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-018-0629-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1007\/s13365-018-0629-1","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}